Posted on March 10, 2022
By Elizabeth Jurica | Bristol Myers Squibb, Principal Scientist
January 11, 2022
By Jennifer Snyder | Novartis Pharmaceuticals, Director, Portfolio Strategy Management for Technical Research and Development Cell & Gene Therapy
I am a Novartis associate. The views expressed in this article are my own and are not endorsed by Novartis. “The greatest success we’ll know is helping others succeed and grow” -Gregory Scott Reid I firmly believe that we truly grow, when we can be a tool for others to develop and grow. At Novartis, […]
January 24, 2022
By Alexander M. Haydl | Boehringer Ingelheim Germany, Head of Late-Stage Development Laboratory and Product Owner of Digital Process Development
January 28, 2022
By Stuart Flanagan | Evotec, Group Leader
December 21, 2021
By Kaja Natland | Organon, Regional President, Asia Pacific & Japan
January 4, 2022
By Rebekah Martin | AstraZeneca, Senior Vice President of Reward and Inclusion
December 7, 2022
By Ahmed Elhusseiny | Roche Pharmaceuticals, Area Head, Asia Pacific
August 31, 2021
By Teresa Foy | Bristol Myers Squibb, Sr Vice President Immuno-Oncology and Cellular Therapy
November 17, 2021
By Bo Quan Tan | Lonza Singapore, Manager of Project Engineering Department
May 20, 2022
By Jason Rudd | Amgen, Statistical Programming Manager
August 19, 2021
By Galym Dauletbakov | Takeda, Business Operations Head UCC
June 24, 2021
By Francis Van Parys | Cytiva, Vice President Commercial Asia Pacific
June 16, 2021
By Rajeev Nair | Merck, Senior Vice President & Head of Asia Pacific - Research Solutions
February 23, 2022
By Jürgen Schrapp | Bayer, Head of R&D Procurement
